Market Cap 199.98M
Revenue (ttm) 16.10M
Net Income (ttm) -42.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -264.41%
Debt to Equity Ratio 0.07
Volume 303,900
Avg Vol 248,998
Day's Range N/A - N/A
Shares Out 36.29M
Stochastic %K 25%
Beta 0.62
Analysts Strong Sell
Price Target $11.62

Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or phys...

Industry: Medical Devices
Sector: Healthcare
Phone: 647 476 1350
Fax: 647 847 3739
Address:
2400 Skymark Avenue, Unit 6, Mississauga, Canada
StockNews_Live
StockNews_Live Mar. 13 at 2:30 PM
$PROF 🎯 STOCK NEWS ALERT 🔥 Sentiment Score: 95/100 🚀 VERY POSITIVE NEWS 📄 Profound Medical Corp. announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic… 📎 https://stocknews.live/news/PROF/captain-trial-comparing-profound-02489.html
0 · Reply
PantySniffer69420
PantySniffer69420 Mar. 13 at 12:23 AM
0 · Reply
PantySniffer69420
PantySniffer69420 Mar. 10 at 3:04 PM
$PROF Here for the gap fill then out.
0 · Reply
QES
QES Mar. 9 at 9:22 PM
$PROF New account coming in Arizona. https://www.linkedin.com/feed/update/urn:li:activity:7435674668663001088/
0 · Reply
StreetwiseReports
StreetwiseReports Mar. 9 at 6:31 PM
Medical Co.'s TULSA-PRO Installed Base Growth and CAPTAIN Trial Data Could Accelerate Adoption in 2026 https://ow.ly/iPIE50YrtLI Leede Financial maintained its rating on Profound Medical Corp. ($PROF:NASDAQ; PRN:TSX), citing strong TULSA-PRO capital sales, expanding installed base, and upcoming CAPTAIN trial results at EAU meeting as key catalysts.
0 · Reply
johntarlick
johntarlick Mar. 9 at 2:58 PM
$PROF sorry folks but there's just too many questions in that call that analysts aren't picking up on. For 18 months now and more, management has been touting interventional MRI as their ticket to unicorn. $PROF was going to ride the iMRI wave and to that end they started a project to add the Siemens Freemax 0.5T system to their list of supported MRI's, indicating a soft launch for Q3/25. It never happened and the best that is now promised is that it will happen 'later in 2026'. But in the meantime, the strategy described in this call has pivoted... back to the original business plan of utilizing the installed base of existing non-interventional MRI's! That means a major engineering effort to modify the product for Freemax is a year late at best, but because it's right off the front burner altogether now, the temporal aspect of that effort (remember your Iron Triangle folks, it's engineering management 101) is just flushed down the drain.
2 · Reply
johntarlick
johntarlick Mar. 9 at 2:49 PM
$PROF So the 14 positions under discussion here, are now 10 as of this morning. They were originally posted on Feb 20 and Feb 26 in two batches of 7 (seven) each. What are the chances that no less than four (4) people were hired in just 10 business days? Or were these just ghost jobs? Were four of them retracted in the aftermath of the earnings call?
0 · Reply
johntarlick
johntarlick Mar. 8 at 3:05 PM
$PROF well i don't think i saw that coming, and neither did the markets in general. On the one hand, i'm inclined to think over-reaction, it's oversold. But on the other hand, there's just some weird language in the call. eg: "... we have launched a strategic TULSA program team, which will use our organizational leverage to ensure successful TULSA program launches. This team will grow procedural volume thereafter. " I believe this references the 14 new hires that went up last week. In other words, it's not enough to get the sale. The customer has to be convinced to use the device, even after a capital sale. Fully 14 people will be hired, to convince customers to use the device they already bought. This technology seems like a slam dunk, why is management making it look so hard?
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 5 at 9:26 PM
$PROF Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.27 up 35.00% YoY • Reported revenue of $5.98M up 61.32% YoY • Profound believes it is on the path to driving high double digit to low triple digit revenue growth and, ultimately, positive cash flows and net profitability.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 5 at 9:26 PM
$PROF Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.27 up 35.00% YoY • Reported revenue of $5.98M up 61.32% YoY • Profound is on track for high double digit to low triple digit revenue growth and expects to achieve positive cash flows and net profitability, with TULSA-PRO installs reaching approximately 120 by 2026.
0 · Reply
Latest News on PROF
Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript

Fri, 06 Mar 2026 01:16:02 -0500 - 9 days ago

Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript


Q4 2025 Profound Medical Corp Earnings Call Transcript

2026-03-06T03:00:30.000Z - 10 days ago

Q4 2025 Profound Medical Corp Earnings Call Transcript


Profound Medical (PROF) Reports Q4 Revenue Below Expectations

2026-03-05T21:59:47.000Z - 10 days ago

Profound Medical (PROF) Reports Q4 Revenue Below Expectations


Profound Medical Q4 Earnings Assessment

2026-03-05T21:30:08.000Z - 10 days ago

Profound Medical Q4 Earnings Assessment


Profound Medical's Earnings: A Preview

2026-03-04T20:03:05.000Z - 11 days ago

Profound Medical's Earnings: A Preview


Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

Tue, 06 Jan 2026 07:45:00 -0500 - 2 months ago

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case


Profound Medical Corp. Announces Closing of Private Placement

Tue, 30 Dec 2025 16:30:00 -0500 - 2 months ago

Profound Medical Corp. Announces Closing of Private Placement


Profound Medical increases private placement to $6.45M

2025-12-24T19:10:26.000Z - 2 months ago

Profound Medical increases private placement to $6.45M


Profound Medical Corp. Announces Upsize of Private Placement

Wed, 24 Dec 2025 13:15:00 -0500 - 2 months ago

Profound Medical Corp. Announces Upsize of Private Placement


Profound Medical (PROF) Surpasses Q3 Revenue Expectations

2025-11-16T11:25:38.000Z - 4 months ago

Profound Medical (PROF) Surpasses Q3 Revenue Expectations


Profound Medical (PROF) Achieves Record Q3 Revenue and Growth

2025-11-16T10:50:32.000Z - 4 months ago

Profound Medical (PROF) Achieves Record Q3 Revenue and Growth


Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript

Thu, 13 Nov 2025 22:11:34 -0500 - 4 months ago

Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript


Profound Medical Reports Strong Third Quarter 2025 Financial Results

Thu, 13 Nov 2025 16:05:00 -0500 - 4 months ago

Profound Medical Reports Strong Third Quarter 2025 Financial Results


Profound Medical to Participate in the Stifel 2025 Healthcare Conference

Tue, 14 Oct 2025 08:30:00 -0400 - 5 months ago

Profound Medical to Participate in the Stifel 2025 Healthcare Conference


Profound Medical: Smokes Is Everywhere, Initiate At Sell

Aug 18, 2025, 7:01 PM EDT - 7 months ago

Profound Medical: Smokes Is Everywhere, Initiate At Sell


Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:24 PM EDT - 7 months ago

Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript

PRN


Profound Medical Announces Second Quarter 2025 Financial Results

Aug 14, 2025, 4:05 PM EDT - 7 months ago

Profound Medical Announces Second Quarter 2025 Financial Results


Profound Medical AUA 2025 Investor Event Agenda

Apr 15, 2025, 7:45 AM EDT - 11 months ago

Profound Medical AUA 2025 Investor Event Agenda


StockNews_Live
StockNews_Live Mar. 13 at 2:30 PM
$PROF 🎯 STOCK NEWS ALERT 🔥 Sentiment Score: 95/100 🚀 VERY POSITIVE NEWS 📄 Profound Medical Corp. announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic… 📎 https://stocknews.live/news/PROF/captain-trial-comparing-profound-02489.html
0 · Reply
PantySniffer69420
PantySniffer69420 Mar. 13 at 12:23 AM
0 · Reply
PantySniffer69420
PantySniffer69420 Mar. 10 at 3:04 PM
$PROF Here for the gap fill then out.
0 · Reply
QES
QES Mar. 9 at 9:22 PM
$PROF New account coming in Arizona. https://www.linkedin.com/feed/update/urn:li:activity:7435674668663001088/
0 · Reply
StreetwiseReports
StreetwiseReports Mar. 9 at 6:31 PM
Medical Co.'s TULSA-PRO Installed Base Growth and CAPTAIN Trial Data Could Accelerate Adoption in 2026 https://ow.ly/iPIE50YrtLI Leede Financial maintained its rating on Profound Medical Corp. ($PROF:NASDAQ; PRN:TSX), citing strong TULSA-PRO capital sales, expanding installed base, and upcoming CAPTAIN trial results at EAU meeting as key catalysts.
0 · Reply
johntarlick
johntarlick Mar. 9 at 2:58 PM
$PROF sorry folks but there's just too many questions in that call that analysts aren't picking up on. For 18 months now and more, management has been touting interventional MRI as their ticket to unicorn. $PROF was going to ride the iMRI wave and to that end they started a project to add the Siemens Freemax 0.5T system to their list of supported MRI's, indicating a soft launch for Q3/25. It never happened and the best that is now promised is that it will happen 'later in 2026'. But in the meantime, the strategy described in this call has pivoted... back to the original business plan of utilizing the installed base of existing non-interventional MRI's! That means a major engineering effort to modify the product for Freemax is a year late at best, but because it's right off the front burner altogether now, the temporal aspect of that effort (remember your Iron Triangle folks, it's engineering management 101) is just flushed down the drain.
2 · Reply
johntarlick
johntarlick Mar. 9 at 2:49 PM
$PROF So the 14 positions under discussion here, are now 10 as of this morning. They were originally posted on Feb 20 and Feb 26 in two batches of 7 (seven) each. What are the chances that no less than four (4) people were hired in just 10 business days? Or were these just ghost jobs? Were four of them retracted in the aftermath of the earnings call?
0 · Reply
johntarlick
johntarlick Mar. 8 at 3:05 PM
$PROF well i don't think i saw that coming, and neither did the markets in general. On the one hand, i'm inclined to think over-reaction, it's oversold. But on the other hand, there's just some weird language in the call. eg: "... we have launched a strategic TULSA program team, which will use our organizational leverage to ensure successful TULSA program launches. This team will grow procedural volume thereafter. " I believe this references the 14 new hires that went up last week. In other words, it's not enough to get the sale. The customer has to be convinced to use the device, even after a capital sale. Fully 14 people will be hired, to convince customers to use the device they already bought. This technology seems like a slam dunk, why is management making it look so hard?
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 5 at 9:26 PM
$PROF Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.27 up 35.00% YoY • Reported revenue of $5.98M up 61.32% YoY • Profound believes it is on the path to driving high double digit to low triple digit revenue growth and, ultimately, positive cash flows and net profitability.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 5 at 9:26 PM
$PROF Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.27 up 35.00% YoY • Reported revenue of $5.98M up 61.32% YoY • Profound is on track for high double digit to low triple digit revenue growth and expects to achieve positive cash flows and net profitability, with TULSA-PRO installs reaching approximately 120 by 2026.
0 · Reply
johntarlick
johntarlick Mar. 2 at 1:26 PM
$PROF the roller coaster at sales continues. 14 new hire positions are up this week. As you recall, in the November 2024 investor event a sales team of 40 was predicted, up from the then 15'ish. Starting in Jan 2025, rapid hiring boosted that to maybe 30. Then in the bloodbath of July 1 2025, many were laid off reducing the count to just 11 (eleven). With these new positions, we'll be up to 25 and back on the road to the promised 40. If that isn't an indication of big numbers to come on thurs, i don't know what is.
0 · Reply
Bmdubb
Bmdubb Feb. 27 at 7:49 PM
$PROF took some profits today. I’ll buy back near 7.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 4:14 PM
$PROF Current Stock Price: $7.16 Contracts to trade: $7.5 PROF Mar 20 2026 Call Entry: $1.19 Exit: $1.58 ROI: 33% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 3:48 PM
$PROF RSI: 39.39, MACD: -0.1814 Vol: 0.52, MA20: 6.97, MA50: 7.46 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Bmdubb
Bmdubb Feb. 18 at 5:11 PM
$PROF finally! Can we get 10 this month?
0 · Reply
RuleBasedReturns
RuleBasedReturns Feb. 18 at 4:23 PM
$PROF Profound Medical provides image-guided ablation systems for cancer treatment. Adoption depends on clinical outcomes and hospital capital budgets. Recurring consumables support margins.
0 · Reply
BioTuesdays
BioTuesdays Feb. 12 at 2:20 PM
$PROF has announced that it has received the 2025/2026 Mount Logan Award from INOVAIT, the Canadian national network for commercializing breakthroughs in image-guided therapy and AI https://biotuesdays.com/2026/02/12/inovait-honors-profound-with-2025-26-mount-logan-award-recognizing-tulsa-procedure-for-prostate-disease/
0 · Reply
macroaxis
macroaxis Feb. 8 at 7:42 AM
$PROF – Volatility Alert: Rising Options Pin Risk Signals Increased Trading Uncertainty https://www.macroaxis.com/stock-options/PROF/Profound-Medical-Corp?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 6 at 1:58 AM
$PROF Current Stock Price: $6.32 Contracts to trade: $7.5 PROF Feb 20 2026 Call Entry: $0.06 Exit: $0.08 ROI: 35% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
johntarlick
johntarlick Feb. 5 at 3:49 PM
$PROF what's the deal? q3 was awesome and q4 and year-end is coming up soon. i was looking to move up possibly $9++ before then.
2 · Reply
BioTuesdays
BioTuesdays Feb. 5 at 3:15 PM
$PROF announced today that PRO FAMILIA Specialist Hospital in Rzeszów, Poland has completed its 500th Sonalleve Procedure. The MRI-guided therapy provides women with a non-surgical alternative for treating common gynecologic conditions—delivering targeted relief with no incisions, no blood loss during the procedure, no overnight hospital stay, and a faster recovery https://biotuesdays.com/2026/02/05/pro-familia-and-profound-mark-500-sonalleve-procedures-expand-access-to-incision-free-womens-healthcare/
0 · Reply
Bmdubb
Bmdubb Jan. 23 at 9:58 PM
$PROF adding dips into the 7s
0 · Reply